| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 04/24/2013 | EP2582667A1 Heterocyclic substituted methoxyphenyl derivatives having an oxo group, method for producing same, and use thereof as gpr40 receptor modulators |
| 04/24/2013 | EP2240454B1 Mesoionic pesticides |
| 04/24/2013 | CN103068827A Fused heterocyclic derivatives as s1p modulators |
| 04/24/2013 | CN103059043A Clavatine A-C and preparation method as well as pharmaceutical composition and application thereof |
| 04/24/2013 | CN103059042A Thiophene derivative and application thereof to medicine |
| 04/24/2013 | CN103059034A Methods for synthesizing securinine natural products flueggine A, norsecurinine, virosaine B and allonorsecurinine |
| 04/24/2013 | CN102015710B Azatricyclic antibiotic compounds |
| 04/23/2013 | US8426595 Gamma secretase modulators |
| 04/23/2013 | US8426584 Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives |
| 04/23/2013 | US8426440 Indolymaleimide derivatives |
| 04/23/2013 | US8426403 Gamma secretase modulators |
| 04/23/2013 | CA2709202C Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
| 04/18/2013 | WO2013055563A1 Compounds for the treatment of hepatitis c |
| 04/18/2013 | WO2013054862A1 Polycyclic pyridone derivative having integrase-inhibiting activity |
| 04/18/2013 | WO2013054822A1 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases |
| 04/18/2013 | US20130096277 Processes and intermediates |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130096109 Pyridone derivative having integrase inhibitory activity |
| 04/18/2013 | US20130096102 Aminopyrimidine derivatives as lrrk2 modulators |
| 04/18/2013 | US20130095066 Compounds for the Treatment of Hepatitis C |
| 04/18/2013 | US20130095063 Compounds for the Treatment of Hepatitis C |
| 04/18/2013 | CA2851218A1 Polycyclic pyridone derivative having integrase-inhibiting activity |
| 04/18/2013 | CA2851087A1 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases |
| 04/17/2013 | EP2581368A1 Cyclic carbodiimide compound |
| 04/17/2013 | CN103044446A Heterocycle quinoline derivatives as well as medicinal salts, preparation method and medicinal application thereof |
| 04/17/2013 | CN102127092B Preparation of Everolimus |
| 04/16/2013 | US8420646 Tricyclic tetrahydroquinoline antibacterial agents |
| 04/16/2013 | US8420623 N, N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 04/16/2013 | CA2637204C Substituted quinolones iii |
| 04/11/2013 | WO2013050938A1 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives |
| 04/11/2013 | WO2013050438A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. |
| 04/11/2013 | WO2013050437A1 Heterocyclylpyri (mi) dinylpyrazole as fungicidals |
| 04/11/2013 | WO2013050434A1 Heterocyclylpyri(mi)dinylpyrazole |
| 04/11/2013 | WO2013050341A1 Azabenzoxazine derivatives as crac modulators |
| 04/11/2013 | WO2013050334A1 Cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
| 04/11/2013 | US20130090348 Polymorphic forms of rifaximin |
| 04/11/2013 | US20130090334 Azabenzoxazine derivatives as crac modulators |
| 04/11/2013 | CA2851142A1 Heterocyclylpyri (mi) dinylpyrazole as fungicidals |
| 04/11/2013 | CA2851037A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases |
| 04/11/2013 | CA2847095A1 Cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
| 04/10/2013 | EP2578591A1 Novel benzoxazine oxazolidinone compounds, preparation methods and uses thereof |
| 04/10/2013 | EP2578186A2 Drug-delivery endovascular stent and method for treating restenosis |
| 04/10/2013 | EP2576567A1 Nitroimidazole derivatives |
| 04/10/2013 | EP2576514A1 Substituted isoquinolines and their use as tubulin polymerization inhibitors |
| 04/10/2013 | EP2576510A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 04/10/2013 | CN103038233A Pyridone and aza-pyridone compounds and methods of use |
| 04/10/2013 | CN103030634A Bicyclo-containing oxazolidinone antibiotics |
| 04/10/2013 | CN102060860B Preparation method of Marbofloxacin |
| 04/10/2013 | CN101195599B 2,4,6-phenyl substituted cyclic ketoenols |
| 04/09/2013 | US8415333 Bronchodilating diazaheteroaryls |
| 04/04/2013 | WO2013049263A1 Substituted bicyclic heteroaryl compounds |
| 04/04/2013 | WO2013048995A1 Compounds for the treatment of hepatitis c |
| 04/04/2013 | WO2013046136A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
| 04/04/2013 | WO2013046029A1 Macrocyclic lrrk2 kinase inhibitors |
| 04/04/2013 | WO2013045653A1 Macrocyclic flt3 kinase inhibitors |
| 04/04/2013 | WO2013045461A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 04/04/2013 | WO2013045373A1 Oxy-cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
| 04/04/2013 | WO2013044865A1 Oxazolidinone antibiotics containing fused ring |
| 04/04/2013 | WO2012161622A3 Incretin hormone secretion stimulators, method for producing and using same |
| 04/04/2013 | US20130085274 Process for the production of a carbodiimide |
| 04/04/2013 | US20130085273 Process for producing an intermediate for a cyclic carbodiimide compound |
| 04/04/2013 | US20130085134 Quinoxaline compound |
| 04/04/2013 | US20130085128 6-(4-Hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 04/04/2013 | CA2850350A1 Macrocyclic lrrk2 kinase inhibitors |
| 04/04/2013 | CA2849999A1 Macrocyclic flt3 kinase inhibitors |
| 04/04/2013 | CA2849995A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
| 04/04/2013 | CA2845191A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 04/04/2013 | CA2844581A1 Oxy-cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
| 04/03/2013 | CN103025744A Aza-bicyclic amine n-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs |
| 04/03/2013 | CN103025743A Method for producing carbodiimide |
| 04/03/2013 | CN103025729A Evaporable organically semiconductive material and use thereof in an optoelectronic component |
| 04/03/2013 | CN103025728A 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 04/03/2013 | CN103025724A 哌啶衍生物 Piperidine derivatives |
| 04/03/2013 | CN103025716A Bicyclic compound derivatives and their use as acc inhibitors |
| 04/03/2013 | CN102285997B Method for preparing chloroallyl beta-lactam antibiotic intermediate |
| 04/02/2013 | US8410131 Cancer treatment |
| 04/02/2013 | US8410119 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/02/2013 | CA2601670C Method for the preparation of maytansinoid esters |
| 04/02/2013 | CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| 03/28/2013 | WO2013044092A1 Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| 03/28/2013 | US20130079511 Bicyclic methylene aziridines and reactions thereof |
| 03/28/2013 | US20130079510 Cyclic carbodiimide compound |
| 03/28/2013 | US20130079366 Benzisoxazoles and Azabenzisoxazoles as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 03/28/2013 | US20130079358 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 03/28/2013 | US20130079357 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 03/28/2013 | US20130079333 Oxy-cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
| 03/28/2013 | US20130079331 Benzoxazepin pi3k inhibitor compounds and methods of use |
| 03/28/2013 | US20130079324 Pyrrolopyrimidine and purine derivatives |
| 03/28/2013 | US20130079321 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 03/28/2013 | US20130079320 Amine Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079306 HETEROCYCLIC COMPOUND AND p27Kip1 DEGRADATION INHIBITOR |
| 03/28/2013 | US20130078214 Compounds for the Treatment of Hepatitis C |
| 03/28/2013 | US20130078185 Nitroimidazole derivatives |
| 03/27/2013 | EP2573090A1 (6,7-dihydro-2-nitro-5h-imidazol[2,1-b][1,3]oxazin-6-yl) amide compounds, preparation methods and uses thereof |
| 03/27/2013 | EP2571883A1 Macrocyclic compounds as trk kinase inhibitors |
| 03/27/2013 | EP2571872A1 Compounds |
| 03/27/2013 | EP2571356A1 Spiro isoxazoline compounds as sstr5 antagonists |
| 03/27/2013 | CN102993213A Organic compounds |
| 03/27/2013 | CN102993212A Picrinine salt and pharmaceutical application thereof |
| 03/27/2013 | CN102993211A Azacyclo-substituted benzo spirooxazine photochromic compound and preparation method thereof |